Literature DB >> 19288259

Contrast-enhanced cardiovascular magnetic resonance in the hyperacute phase of ST-elevation myocardial infarction.

Eric Larose1, Julie Côté, Josep Rodés-Cabau, Bernard Noël, Gerald Barbeau, Edith Bordeleau, Santiago Miró, Bernard Brochu, Robert Delarochellière, Olivier F Bertrand.   

Abstract

Cardiovascular magnetic resonance (CMR) very early after primary percutaneous coronary intervention (PPCI) may lead to instability or early stent complications. However, CMR in the hyperacute phase of STEMI may improve risk stratification. We investigated feasibility and safety of CMR in the hyperacute phase of STEMI immediately after PPCI. One hundred and twenty eight consecutive patients immediately after PPCI for STEMI. Sixty four underwent CMR <12 h after PPCI versus 64 matched controls. Outcomes were followed over 6 months. CMR in hyperacute STEMI was not associated with in-hospital death, infarct expansion, or urgent revascularization (P = NS). CMR (32 ml gadolinium contrast) immediately after PPCI (180 ml iodine contrast) did not increase nephropathy. CMR did not increase major adverse cardiac events (5 vs. 8%, P = 0.16) or recurrence of angina (6 vs. 8%, P = 0.73) at 6 months. CMR immediately after PPCI is feasible and safe, allowing very early risk stratification in STEMI.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19288259     DOI： 10.1007/s10554-009-9451-4

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN： 1569-5794            Impact factor:   2.357


  38 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Coronary arterial stents: safety and artifacts during MR imaging.

Authors:  J Hug; E Nagel; A Bornstedt; B Schnackenburg; H Oswald; E Fleck
Journal:  Radiology       Date:  2000-09       Impact factor: 11.105

3.  Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality.

Authors:  Andrew T Yan; Adolphe J Shayne; Kenneth A Brown; Sandeep N Gupta; Carmen W Chan; Tuan M Luu; Marcelo F Di Carli; H Glenn Reynolds; William G Stevenson; Raymond Y Kwong
Journal:  Circulation       Date:  2006-06-26       Impact factor: 29.690

4.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.

Authors:  R J Kim; D S Fieno; T B Parrish; K Harris; E L Chen; O Simonetti; J Bundy; J P Finn; F J Klocke; R M Judd
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

5.  Safety of magnetic resonance imaging one to three days after bare metal and drug-eluting stent implantation.

Authors:  Italo Porto; Joseph Selvanayagam; Vaishali Ashar; Stefan Neubauer; Adrian P Banning
Journal:  Am J Cardiol       Date:  2005-08-01       Impact factor: 2.778

6.  Gadolinium-based contrast agents and nephrotoxicity in patients undergoing coronary artery procedures.

Authors:  Carlo Briguori; Antonio Colombo; Flavio Airoldi; Gloria Melzi; Iassen Michev; Mauro Carlino; Matteo Montorfano; Alaide Chieffo; Raimondo Bellanca; Bruno Ricciardelli
Journal:  Catheter Cardiovasc Interv       Date:  2006-02       Impact factor: 2.692

7.  Renal failure in 57 925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media.

Authors:  P Liss; P B Persson; P Hansell; B Lagerqvist
Journal:  Kidney Int       Date:  2006-09-27       Impact factor: 10.612

8.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction).

Authors:  Elliott M Antman; Daniel T Anbe; Paul Wayne Armstrong; Eric R Bates; Lee A Green; Mary Hand; Judith S Hochman; Harlan M Krumholz; Frederick G Kushner; Gervasio A Lamas; Charles J Mullany; Joseph P Ornato; David L Pearle; Michael A Sloan; Sidney C Smith; Joseph S Alpert; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Gabriel Gregoratos; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Alice K Jacobs
Journal:  Circulation       Date:  2004-08-31       Impact factor: 29.690

9.  Ventricular tachycardia in the infarcted, Langendorff-perfused human heart: role of the arrangement of surviving cardiac fibers.

Authors:  J M de Bakker; R Coronel; S Tasseron; A A Wilde; T Opthof; M J Janse; F J van Capelle; A E Becker; G Jambroes
Journal:  J Am Coll Cardiol       Date:  1990-06       Impact factor: 24.094

10.  Influence of time-to-treatment, TIMI-flow grades, and ST-segment resolution on infarct size and infarct transmurality as assessed by delayed enhancement magnetic resonance imaging.

Authors:  Holger Thiele; Mathias J Kappl; Axel Linke; Sandra Erbs; Enno Boudriot; Alexander Lembcke; Dietmar Kivelitz; Gerhard Schuler
Journal:  Eur Heart J       Date:  2007-06-06       Impact factor: 29.983
View more
  5 in total

1.  Cardiac magnetic resonance imaging safety following percutaneous coronary intervention.

Authors:  Jason W Curtis; Donna C Lesniak; James H Wible; Pamela K Woodard
Journal:  Int J Cardiovasc Imaging       Date:  2013-04-27       Impact factor: 2.357

Review 2.  Assessment of acute myocardial infarction: current status and recommendations from the North American society for Cardiovascular Imaging and the European Society of Cardiac Radiology.

Authors:  Arthur E Stillman; Matthijs Oudkerk; David Bluemke; Jens Bremerich; Fabio P Esteves; Ernest V Garcia; Matthias Gutberlet; W Gregory Hundley; Michael Jerosch-Herold; Dirkjan Kuijpers; Raymond K Kwong; Eike Nagel; Stamatios Lerakis; John Oshinski; Jean-François Paul; Richard Underwood; Bernd J Wintersperger; Michael R Rees
Journal:  Int J Cardiovasc Imaging       Date:  2010-10-24       Impact factor: 2.357

3.  The role of cardiac magnetic resonance in the evaluation of patients presenting with suspected or confirmed acute coronary syndrome.

Authors:  Loren P Budge; Michael Salerno
Journal:  Cardiol Res Pract       Date:  2011-10-19       Impact factor: 1.866

4.  Cardiac magnetic resonance imaging analysis in STEMI: quantitative or still visual?

Authors:  E E van der Wall; J J Bax; J H Reiber
Journal:  Int J Cardiovasc Imaging       Date:  2010-05-08       Impact factor: 2.357

5.  Cardiac magnetic resonance imaging in primary PCI: additional value?

Authors:  E E van der Wall; J J Bax; J W Jukema; M J Schalij
Journal:  Int J Cardiovasc Imaging       Date:  2009-05-26       Impact factor: 2.357
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.